Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

748
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
748
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

783
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
783
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

852
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
852
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

834
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
834
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

467
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
467
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

670
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
670

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular mechanisms of <i>ARMC5</i> mutations in adrenal pathophysiology.

Current opinion in endocrine and metabolic research·2020
Same author

Prkar1a haploinsufficiency ameliorates the growth hormone excess phenotype in Aip-deficient mice.

Human molecular genetics·2020
Same author

Letter to the Editor from Berthon: "Cardiac Myxoma Caused by Fumarate Hydratase Gene Deletion in Patient With Cortisol-Secreting Adrenocortical Adenoma".

The Journal of clinical endocrinology and metabolism·2020
Same author

A Century After the Description of "Hormones", Our Golden Jubilee Celebration Goes on with What is New in Endocrine Oncology: And a Lot is New!

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2020
Same author

Curative resection of an aldosteronoma causing primary aldosteronism in the second trimester of pregnancy.

Endocrinology, diabetes & metabolism case reports·2020
Same author

c-KIT oncogene expression in PRKAR1A-mutant adrenal cortex.

Endocrine-related cancer·2020

Related Experiment Video

Updated: Apr 8, 2026

Metacarpal Small Incision for Carpal Tunnel Syndrome
04:08

Metacarpal Small Incision for Carpal Tunnel Syndrome

Published on: April 5, 2024

2.0K

Carney complex: an update.

Ricardo Correa1, Paraskevi Salpea1, Constantine A Stratakis2

  • 1Section on Endocrinology and GeneticsProgram on Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Drive, Building 10, NIH-Clinical Research Center, Room 1-3330, MSC1103, Bethesda, Maryland 20892, USA.

European Journal of Endocrinology
|July 2, 2015
PubMed
Summary

Carney complex (CNC) is a rare genetic disorder causing skin lesions, myxomas, and endocrine tumors due to PRKAR1A gene mutations. Recent findings link defects in PRKACA and PRKACB genes to CNC, particularly concerning adrenal tumors and Cushing's syndrome.

More Related Videos

Screening of Axonal Degeneration in Carpal Tunnel Syndrome Using Ultrasonography and Nerve Conduction Studies
06:40

Screening of Axonal Degeneration in Carpal Tunnel Syndrome Using Ultrasonography and Nerve Conduction Studies

Published on: January 11, 2019

12.5K
Coherent Anti-Stokes Raman Spectroscopy CARS Application for Imaging Myelination in Brain Slices
04:08

Coherent Anti-Stokes Raman Spectroscopy CARS Application for Imaging Myelination in Brain Slices

Published on: July 22, 2022

3.2K

Related Experiment Videos

Last Updated: Apr 8, 2026

Metacarpal Small Incision for Carpal Tunnel Syndrome
04:08

Metacarpal Small Incision for Carpal Tunnel Syndrome

Published on: April 5, 2024

2.0K
Screening of Axonal Degeneration in Carpal Tunnel Syndrome Using Ultrasonography and Nerve Conduction Studies
06:40

Screening of Axonal Degeneration in Carpal Tunnel Syndrome Using Ultrasonography and Nerve Conduction Studies

Published on: January 11, 2019

12.5K
Coherent Anti-Stokes Raman Spectroscopy CARS Application for Imaging Myelination in Brain Slices
04:08

Coherent Anti-Stokes Raman Spectroscopy CARS Application for Imaging Myelination in Brain Slices

Published on: July 22, 2022

3.2K

Area of Science:

  • Genetics
  • Endocrinology
  • Molecular Biology

Background:

  • Carney complex (CNC) is a rare autosomal dominant syndrome.
  • It is characterized by skin/mucosal lentigination, myxomas, and endocrine tumors.
  • CNC is primarily caused by inactivating mutations in the PRKAR1A gene.

Purpose of the Study:

  • To review the clinical features, diagnosis, treatment, and molecular etiology of Carney complex.
  • To discuss the role of PRKAR1A gene mutations in CNC.
  • To highlight recent findings on PRKACA and PRKACB defects in CNC, especially regarding adrenal tumors and Cushing's syndrome.

Main Methods:

  • Literature review of Carney complex.
  • Analysis of genetic mutations associated with CNC.
  • Review of clinical manifestations and diagnostic criteria.

Main Results:

  • PRKAR1A gene mutations are the primary cause of CNC.
  • Defects in PRKACA and PRKACB genes are newly associated with CNC.
  • These PRKACA/PRKACB defects are particularly linked to adrenal tumors and Cushing's syndrome.

Conclusions:

  • Carney complex has a complex molecular etiology involving multiple protein kinase A subunits.
  • Understanding these genetic defects is crucial for diagnosis and management.
  • Further research into PRKACA and PRKACB roles may improve CNC patient outcomes.